car-t expectations
Published 5 years ago • 51 plays • Length 2:55Download video MP4
Download video MP3
Similar videos
-
1:33
patient selection for car-t in all
-
1:52
perspectives on patient selection for car-t therapy
-
4:34
future perspectives in car-t therapy
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
4:17
preparing for the commercialization of car-t products
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
1:14
components of the car-hematotox model which allow for prediction of icaht following car-t
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
17:18
aina oliver-caldés: academic car-t cells for myeloma | #16 | trainee pearls
-
9:25
mgus diagnosis: a step-by-step approach
-
3:49
strategies to improve cost & access to car-t therapy
-
2:10
managing hematologic toxicity associated with car-t therapy & insights into the car-hematotox score
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
1:38
challenges of car-t therapy in the real-world setting
-
0:51
developing universal car-t therapies for t-all
-
2:12
expanding the reach of car-t
-
1:18
the role of social media in the development of car-t therapy
-
3:57
mechanisms and management of short- and long-term car-t toxicities
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:10
universal car-t therapy for t-all
-
3:37
stratifying patients receiving car-t cell therapy with car-hematotox